Search Results 281-290 of 16022 for pharmacogenetics
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell ...
Copland, our lab strives to create personalized cancer models and develop molecular-targeted therapies, focusing on renal cancer, thyroid cancer, liver cancer ...
The purpose of this study is to assess the effectiveness and safety of Lubiprostone in pediatric patients, aged ≥ 6 years to < 18 years, diagnosed with ...
Learn more about causes, symptoms, treatment and self-care tips for this embarrassing condition that causes heavy sweating unrelated to heat or exercise.
The purpose of this study is to determine the safety of using an autologous mesenchymal stromal cell (MSC) coated fistula plug in people with rectovaginal ...
The purpose of this study is to evaluate the association between a baseline comprehensive geriatric assessment (cGA) and chemotherapy toxicity in the first ...
Among persons with Immunoglobulin G subclass 4 Related Disease (IgG4)-related disease who have persistent or recurrent disease despite standard therapies, does ...
Gastrointestinal Barrier Function: Madhusudan Grover · Gastrointestinal Mechanotransduction: Arthur Beyder · Gene Editing and Cellular Engineering: David (Chun- ...
Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...
Learn about a healthcare career as a molecular genetics technologist, what they do, where they work, and programs at Mayo Clinic College of Medicine and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.